IND-Enabling Development of Rx100 as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome
Award Notice Posted
- Solicitation number
- HHS-NIH-NIAID-BAA2017-1
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HHSN272201800052C
- NAICS code
- 541713 Research and Development in Nanotechnology
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
Awarded Vendors: RxBio, Inc.. Contract Award Dollar Amount: $4,573,082. Contract Award Date: 2018-08-30.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Adjuvant Development Program-Research Area 001 | Award Notice | |
| Adjuvant Development Program-Research Area 001 | Award Notice | |
| Adjuvant Development Program-Research Area 001 | Award Notice | |
| This notice | Award Notice |
4 of 8 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity